The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
WQ Li, HF Guo, LY Li, YF Zhang, JW Cui - Cancer Medicine, 2021 - Wiley Online Library
Introduction Traditional cancer therapy has many disadvantages such as low selectivity and
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …
[HTML][HTML] The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
WQ Li, HF Guo, LY Li, YF Zhang, JW Cui - Cancer Medicine, 2021 - ncbi.nlm.nih.gov
Method By reviewing published literature and the current progress of ADCs, we aimed to
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
WQ Li, HF Guo, LY Li, YF Zhang, JW Cui - Cancer Medicine, 2021 - search.proquest.com
Method By reviewing published literature and the current progress of ADCs, we aimed to
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.
WQ Li, HF Guo, LY Li, YF Zhang, JW Cui - Cancer Medicine, 2021 - europepmc.org
Method By reviewing published literature and the current progress of ADCs, we aimed to
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a …
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
WQ Li, HF Guo, LY Li, YF Zhang… - Cancer medicine, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Traditional cancer therapy has many disadvantages such as low selectivity and
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.
WQ Li, HF Guo, LY Li, YF Zhang, JW Cui - Cancer Medicine, 2021 - search.ebscohost.com
Introduction: Traditional cancer therapy has many disadvantages such as low selectivity and
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …
high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance …